Literature DB >> 12147199

Dynamic effects of leflunomide on IL-1, IL-6, and TNF-alpha activity produced from peritoneal macrophages in adjuvant arthritis rats.

Wei-Dong Li1, Guo-Xia Ran, Hui-Ling Teng, Zhi-Bin Lin.   

Abstract

AIM: To investigate the effects of leflunomide (LEF) on modulating interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor- alpha (TNF-alpha) production induced by lipopolysaccharide (LPS) in peritoneal macrophages (PMphi) in adjuvant arthritis rats and elucidate the possible mechanisms of antiinflammatory and antirheumatoid effects of LEF.
METHODS: Freund's complete adjuvant was injected in the hind footpad of rats to induce adjuvant arthritis (AA) rat model. The PMphi samples were taken at different time after medication. IL-1, IL-6, and TNF-alpha activities released from PMphi were measured by ELISA method or bioassay method.
RESULTS: Production of IL-1, IL-6, and TNF-alpha was increased in the culture supernatant of PMphi in AA model rat. LEF could inhibit LPS-induced release of IL-1 and TNF-alpha from PMphi of the AA rats and the inhibitory effects were extremely rapid. LEF (10, 25 mg/kg) administrated for 21d could inhibit IL-6 release from PMphi in AA rats.
CONCLUSION: The antiinflammatory mechanisms of LEF in AA rats might be related to inhibitory level of IL-1, IL-6, and TNF-alpha from PMphi in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12147199

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  8 in total

1.  Xiaoyao-Qingluoyin Cure Adjuvant-Induced Arthritis by Easing LPS Response-Related Pathway-Mediated Immune Abnormality.

Authors:  Dan-Feng Li; Chen-Qiong Xie; Yi-Jin Wu; Chao Shi; Chao-Fan Ji; Yi-Fang Hu; Qiang Liao; Yan Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-25       Impact factor: 2.650

2.  Effect of leflunomide on immunological liver injury in mice.

Authors:  Hong-Wei Yao; Jun Li; Yong Jin; Yun-Fang Zhang; Chang-Yu Li; Shu-Yun Xu
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

3.  A 771726, the active metabolite of leflunomide, inhibits TNF-alpha and IL-1 from Kupffer cells.

Authors:  Hong Wei Yao; Jun Li; Ji Qiang Chen; Shu Yun Xu
Journal:  Inflammation       Date:  2004-04       Impact factor: 4.092

4.  Does leflunomide attenuate the sepsis-induced acute lung injury?

Authors:  Erdogan Ozturk; Semra Demirbilek; Zekine Begec; Murat Surucu; Ersin Fadillioglu; Hale Kirimlioglu; M Ozcan Ersoy
Journal:  Pediatr Surg Int       Date:  2008-05-31       Impact factor: 1.827

5.  Protective effects of leflunomide against ischemia-reperfusion injury of the rat liver.

Authors:  Abdurrahman Karaman; Ersin Fadillioglu; Emine Turkmen; Erkan Tas; Zumrut Yilmaz
Journal:  Pediatr Surg Int       Date:  2006-03-24       Impact factor: 1.827

6.  Synthesis and Biological Evaluation of Novel N-phenyl-5-carboxamidyl Isoxazoles as Potential Chemotherapeutic Agents for Colon Cancer.

Authors:  Jiajiu Shaw; Ben Chen; Jean P Bourgault; Hao Jiang; Narendra Kumar; Jayshree Mishra; Frederick A Valeriote; Joe Media; Kevin Bobbitt; Halina Pietraszkiewicz; Matthew Edelstein; Peter R Andreana
Journal:  Am J Biomed Sci       Date:  2012

7.  Salivary interleukin 6, interleukin 8, interleukin 17A, and tumour necrosis factor α levels in patients with periodontitis and rheumatoid arthritis.

Authors:  Tomasz Kaczyński; Jakub Wroński; Piotr Głuszko; Tomasz Kryczka; Andrzej Miskiewicz; Bartłomiej Górski; Marek Radkowski; Damian Strzemecki; Paweł Grieb; Renata Górska
Journal:  Cent Eur J Immunol       Date:  2019-09-30       Impact factor: 2.085

Review 8.  SARS-CoV-2 Infection and Risk Management in Multiple Sclerosis.

Authors:  Amado Diaz de la Fe; Alejandro Armando Peláez Suárez; Marinet Fuentes Campos; Maivis Noemí Cabrera Hernández; Carlos-Alberto Goncalves; Stephen Schultz; Dario Siniscalco; Maria Angeles Robinson-Agramonte
Journal:  Diseases       Date:  2021-04-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.